WGU D116 Advanced Pharmacology OA & ACTUAL EXAM 2026/2027 |
Verified Questions and Correct Detailed Answers | Pass Guaranteed – A+
Graded
Questions 1–250
1. Which of the following best describes pharmacokinetics?
A) The study of drug effects on the body
B) The study of drug absorption, distribution, metabolism, and excretion
(ADME)
C) The study of drug toxicity
D) The study of drug interactions
Answer B: The study of drug absorption, distribution, metabolism, and
excretion (ADME)
Rationale: Pharmacokinetics is "what the body does to the drug" and
encompasses ADME. Pharmacodynamics is "what the drug does to the body."
,2. A nurse practitioner is assessing a client with hepatic impairment who is
prescribed a medication metabolized by the CYP3A4 enzyme. Which
pharmacokinetic process is most affected?
A) Absorption
B) Distribution
C) Metabolism
D) Excretion
Answer C: Metabolism
Rationale: Hepatic impairment primarily alters metabolism (Phase I reactions
via CYP enzymes like CYP3A4). This can lead to prolonged drug half-life and
increased toxicity risk.
3. The "first-pass effect" refers to:
A) Rapid intravenous administration
B) The binding of a drug to plasma proteins
C) The metabolism of a drug in the liver before reaching systemic circulation
D) The excretion of a drug through the kidneys
Answer C: The metabolism of a drug in the liver before reaching systemic
circulation
Rationale: First-pass metabolism occurs when orally administered drugs are
metabolized in the liver before entering systemic circulation, reducing
bioavailability.
,4. Which route of administration completely bypasses the first-pass effect?
A) Oral
B) Rectal
C) Sublingual
D) Enteric-coated oral
Answer C: Sublingual
Rationale: Sublingual administration allows direct absorption into systemic
circulation, completely bypassing hepatic first-pass metabolism.
5. Bioavailability is defined as:
A) The total amount of drug in the body
B) The fraction of an administered dose that reaches systemic circulation
unchanged
C) The rate at which a drug is eliminated
D) The volume of plasma cleared of drug per unit time
Answer B: The fraction of an administered dose that reaches systemic
circulation unchanged
Rationale: Bioavailability (F) is the fraction of administered drug that reaches
systemic circulation unchanged. Oral drugs typically have lower bioavailability
due to first-pass metabolism.
, 6. A drug with a narrow therapeutic index requires:
A) Less frequent monitoring
B) Close monitoring of serum drug levels
C) No special precautions
D) Higher doses for efficacy
Answer B: Close monitoring of serum drug levels
Rationale: Narrow therapeutic index drugs have a small margin between
therapeutic and toxic doses, requiring careful serum level monitoring.
7. In pharmacodynamics, a drug that binds to a receptor and activates it to
produce a full biological response is classified as:
A) Antagonist
B) Partial agonist
C) Inverse agonist
D) Full agonist
Answer D: Full agonist
Rationale: Full agonists have both high affinity and high intrinsic activity, fully
activating receptors to produce a maximal response.
Verified Questions and Correct Detailed Answers | Pass Guaranteed – A+
Graded
Questions 1–250
1. Which of the following best describes pharmacokinetics?
A) The study of drug effects on the body
B) The study of drug absorption, distribution, metabolism, and excretion
(ADME)
C) The study of drug toxicity
D) The study of drug interactions
Answer B: The study of drug absorption, distribution, metabolism, and
excretion (ADME)
Rationale: Pharmacokinetics is "what the body does to the drug" and
encompasses ADME. Pharmacodynamics is "what the drug does to the body."
,2. A nurse practitioner is assessing a client with hepatic impairment who is
prescribed a medication metabolized by the CYP3A4 enzyme. Which
pharmacokinetic process is most affected?
A) Absorption
B) Distribution
C) Metabolism
D) Excretion
Answer C: Metabolism
Rationale: Hepatic impairment primarily alters metabolism (Phase I reactions
via CYP enzymes like CYP3A4). This can lead to prolonged drug half-life and
increased toxicity risk.
3. The "first-pass effect" refers to:
A) Rapid intravenous administration
B) The binding of a drug to plasma proteins
C) The metabolism of a drug in the liver before reaching systemic circulation
D) The excretion of a drug through the kidneys
Answer C: The metabolism of a drug in the liver before reaching systemic
circulation
Rationale: First-pass metabolism occurs when orally administered drugs are
metabolized in the liver before entering systemic circulation, reducing
bioavailability.
,4. Which route of administration completely bypasses the first-pass effect?
A) Oral
B) Rectal
C) Sublingual
D) Enteric-coated oral
Answer C: Sublingual
Rationale: Sublingual administration allows direct absorption into systemic
circulation, completely bypassing hepatic first-pass metabolism.
5. Bioavailability is defined as:
A) The total amount of drug in the body
B) The fraction of an administered dose that reaches systemic circulation
unchanged
C) The rate at which a drug is eliminated
D) The volume of plasma cleared of drug per unit time
Answer B: The fraction of an administered dose that reaches systemic
circulation unchanged
Rationale: Bioavailability (F) is the fraction of administered drug that reaches
systemic circulation unchanged. Oral drugs typically have lower bioavailability
due to first-pass metabolism.
, 6. A drug with a narrow therapeutic index requires:
A) Less frequent monitoring
B) Close monitoring of serum drug levels
C) No special precautions
D) Higher doses for efficacy
Answer B: Close monitoring of serum drug levels
Rationale: Narrow therapeutic index drugs have a small margin between
therapeutic and toxic doses, requiring careful serum level monitoring.
7. In pharmacodynamics, a drug that binds to a receptor and activates it to
produce a full biological response is classified as:
A) Antagonist
B) Partial agonist
C) Inverse agonist
D) Full agonist
Answer D: Full agonist
Rationale: Full agonists have both high affinity and high intrinsic activity, fully
activating receptors to produce a maximal response.
